DSAM Partners (London) Ltd - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 72 filers reported holding UROGEN PHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
DSAM Partners (London) Ltd ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q2 2018$6,349,000
-34.2%
127,588
-34.3%
1.28%
-21.9%
Q1 2018$9,652,000
+90.0%
194,250
+42.3%
1.64%
+91.8%
Q4 2017$5,079,000
+116.3%
136,500
+83.2%
0.85%
+161.2%
Q3 2017$2,348,00074,5000.33%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2018
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders